Stevanato Group SpA - Asset Resilience Ratio
Stevanato Group SpA (STVN) has an Asset Resilience Ratio of 0.04% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Stevanato Group SpA strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2018–2025)
This chart shows how Stevanato Group SpA's Asset Resilience Ratio has changed over time. See Stevanato Group SpA balance sheet independence to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Stevanato Group SpA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see STVN market cap overview.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $1.06 Million | 0.04% |
| Total Liquid Assets | $1.06 Million | 0.04% |
Asset Resilience Insights
- Limited Liquidity: Stevanato Group SpA maintains only 0.04% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Stevanato Group SpA Industry Peers by Asset Resilience Ratio
Compare Stevanato Group SpA's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Tecan Group AG
SW:TECN |
Medical Instruments & Supplies | 20.48% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 46.84% |
|
SWS Hemodialysis Care Co. Ltd. A
SHG:688410 |
Medical Instruments & Supplies | 38.45% |
|
Formosa Optical Technology Co Ltd
TWO:5312 |
Medical Instruments & Supplies | 46.32% |
|
ZEN Graphene Solutions Ltd
V:ZEN |
Medical Instruments & Supplies | 4.79% |
|
GETS Global Bhd
KLSE:5079 |
Medical Instruments & Supplies | 0.03% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 3.36% |
Annual Asset Resilience Ratio for Stevanato Group SpA (2018–2025)
The table below shows the annual Asset Resilience Ratio data for Stevanato Group SpA.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.09% | $2.20 Million | $2.54 Billion | -- |
| 2024-12-31 | 0.00% | $0.00 | $2.33 Billion | -- |
| 2023-12-31 | 0.04% | $749.00K | $2.07 Billion | -1.65pp |
| 2022-12-31 | 1.68% | $27.91 Million | $1.66 Billion | -0.23pp |
| 2021-12-31 | 1.91% | $27.17 Million | $1.42 Billion | -2.37pp |
| 2020-12-31 | 4.29% | $41.52 Million | $967.98 Million | -0.34pp |
| 2019-12-31 | 4.63% | $40.88 Million | $882.18 Million | -0.50pp |
| 2018-12-31 | 5.14% | $40.14 Million | $781.58 Million | -- |
About Stevanato Group SpA
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprisi… Read more